Basel, Switzerland

Miloud Achour

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miloud Achour. Retrieved from https://idiyas.com/inventor/miloud-achour

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miloud Achour: Innovator in Pharmaceutical Composition

Introduction

Miloud Achour is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative formulations.

Latest Patents

Achour holds a patent for a formulation comprising a benzothiazolone compound. The patent details a pharmaceutical composition in solid oral dosage form that includes (R)-7-(2-(1-(4-butoxyphenyl)-2-methylpropan-2-ylamino)-1-hydroxyethyl)-5-hydroxybenzo[d]thiazol-2(3H)-one acetate salt. This invention showcases his expertise in developing effective pharmaceutical solutions.

Career Highlights

Miloud Achour is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative drug formulations that can improve patient outcomes.

Collaborations

Achour has collaborated with notable colleagues, including Robin Alec Fairhurst and Arnaud Grandeury. These partnerships have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Miloud Achour is a distinguished inventor whose work in pharmaceutical compositions has the potential to impact the healthcare industry significantly. His innovative approach and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…